SynthesisFrontiers in pharmacology2026
Effects of
Synthesis in Frontiers in pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
- Adjunctive Ashwagandha (Nutrients · 2026Pooled it
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: This study aimed to systematically review and evaluate the effects of Methods: Following PRISMA guidelines, we searched PubMed, Web of Science, Cochrane Library, and Embase from inception to 1 February 2026. Ramdom control trials were included to evaluate the effects of Ashwagandha on cognitive function, musclestrength, testosterone, body weight, and body fat percentage by meta-analysis using Stata 14. A random-effects model was used to calculate standardized mean differences (SMD) with 95% confidence intervals. To assess the heterogeneity, sensitivity analyses and subgroup analyses were conducted. Methodological quality and risk of bias were assessed with RoB 2, evidence certainty for each outcome was evaluated with GRADE system, and botanical reporting was assessed with the ConPhyMP checklist. Results: Twenty studies with 1,249 participants were included. Ashwagandha significantly improved memory (SMD = 0.52; 95% CI: 0.27-0.78; P < 0.001; I Conclusion: Ashwagandha supplementation significantly improved several aspects of cognitive function (including global cognitive, memory, attention and processing speed, executive function, and visuospatial ability), as well as serum testosterone and muscle strength in adults, but did not affect body weight or body fat percentage. Systematic Review Registration: https://www.crd.york.ac.uk/PROSPERO/view/CRD420261292996.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.